Onderneming Illumina, Inc.
Aandelen
ILMN
US4523271090
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
118 USD | +10,47% | +17,29% | -14,88% |
13:26 | ILLUMINA, INC. : TD Cowen vindt het aandeel niet inspirerend | ZM |
05/06 | ILLUMINA, INC. : Nephron Research herziet advies naar Neutraal | ZM |
Vakgebied
- verkoop van producten (84,1%): instrumenten voor sequentiebepaling, genotypering, genetische expressie, enz;
- verkoop van diensten (15,9%).
De netto-omzet is als volgt geografisch verdeeld: Verenigde Staten (52,4%), Noord- en Zuid-Amerika (3,6%), Europa (25,3%), Azië/Pacific/Midden-Oosten/Afrika (10,2%) en China/Taiwan/Hongkong (8,5%).
Aantal werknemers: 10 615
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Core Illumina
98,5
%
| 4 553 | 99,3 % | 4 438 | 98,5 % | -2,53% |
Grail
2,1
%
| 55 | 1,2 % | 93 | 2,1 % | +69,09% |
Eliminations
-0,6
%
| -24 | -0,5 % | -27 | -0,6 % | +12,50% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
52,4
%
| 2 290 | 50,0 % | 2 359 | 52,4 % | +3,01% |
Europe
25,3
%
| - | - | 1 140 | 25,3 % | - |
Asia-Pacific, Middle East and Africa
10,2
%
| 418 | 9,1 % | 459 | 10,2 % | +9,81% |
Greater China
8,5
%
| 472 | 10,3 % | 384 | 8,5 % | -18,64% |
Americas
3,6
%
| 189 | 4,1 % | 162 | 3,6 % | -14,29% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacob Thaysen
CEO | Chief Executive Officer | 49 | 25-09-23 |
Steven Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Carissa Rollins
CTO | Chief Tech/Sci/R&D Officer | 54 | 14-03-22 |
Kevin Pegels
COO | Chief Operating Officer | 57 | 01-11-21 |
Investor Relations Contact | - | 01-12-21 | |
Bryan Crane
PRN | Corporate Officer/Principal | - | - |
Scott Ericksen
AUD | Comptroller/Controller/Auditor | 52 | 01-11-13 |
Bas Verhoef
PRN | Corporate Officer/Principal | - | 05/01 |
Charles Dadswell
LAW | General Counsel | 65 | 22-04-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Epstein
BRD | Director/Board Member | 58 | 29-11-12 |
Chairman | 60 | 02-06-23 | |
Caroline Dorsa
BRD | Director/Board Member | 64 | 27-01-17 |
Scott Ullem
BRD | Director/Board Member | 57 | 02-06-23 |
Philip Schiller
BRD | Director/Board Member | 63 | 28-07-16 |
Gary Guthart
BRD | Director/Board Member | 58 | 01-12-17 |
Scott Gottlieb
BRD | Director/Board Member | 51 | 04-02-20 |
Susan Siegel
BRD | Director/Board Member | 63 | 05-02-19 |
Frances Arnold
BRD | Director/Board Member | 67 | 28-01-16 |
Jacob Thaysen
CEO | Chief Executive Officer | 49 | 25-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 199 300 000 | 158 869 731 ( 79,71 %) | 40 000 000 ( 20,07 %) | 79,71 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Illumina Singapore Pte Ltd.
| |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. |
Miscellaneous Commercial Services
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,88% | 17,01 mld. | |
+9,46% | 220 mld. | |
+16,21% | 198 mld. | |
+23,65% | 148 mld. | |
+31,56% | 112 mld. | |
+4,68% | 66,17 mld. | |
+15,10% | 52,47 mld. | |
+4,85% | 50,77 mld. | |
-3,78% | 38,97 mld. | |
-0,52% | 35,13 mld. |
- Beurs
- Aandelen
- Koers ILMN
- Onderneming Illumina, Inc.